WO2002010772A1 - Method of analyzing accumulated fat content in adipocytes - Google Patents

Method of analyzing accumulated fat content in adipocytes Download PDF

Info

Publication number
WO2002010772A1
WO2002010772A1 PCT/JP2001/006132 JP0106132W WO0210772A1 WO 2002010772 A1 WO2002010772 A1 WO 2002010772A1 JP 0106132 W JP0106132 W JP 0106132W WO 0210772 A1 WO0210772 A1 WO 0210772A1
Authority
WO
WIPO (PCT)
Prior art keywords
adipocytes
fat content
accumulated fat
analyzing
analyzing accumulated
Prior art date
Application number
PCT/JP2001/006132
Other languages
French (fr)
Japanese (ja)
Inventor
Masako Nishizawa
Megumi Akiyoshi
Hiroko Murakami
Original Assignee
Sumitomo Chemical Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Company, Limited filed Critical Sumitomo Chemical Company, Limited
Priority to AU2001271054A priority Critical patent/AU2001271054A1/en
Publication of WO2002010772A1 publication Critical patent/WO2002010772A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method of analyzing the content of accumulated fat characterized by comprising: (1) the first step of bringing adipocytes into contact with a fat accumulation promoting protein having a molecular weight of about 6,000 or more and a test substance; and (2) the second step of, after the completion of the operation in the above step (1), quantifying the fat contained in the adipocytes.
PCT/JP2001/006132 2000-07-31 2001-07-16 Method of analyzing accumulated fat content in adipocytes WO2002010772A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001271054A AU2001271054A1 (en) 2000-07-31 2001-07-16 Method of analyzing accumulated fat content in adipocytes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000230781 2000-07-31
JP2000-230781 2000-07-31

Publications (1)

Publication Number Publication Date
WO2002010772A1 true WO2002010772A1 (en) 2002-02-07

Family

ID=18723695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006132 WO2002010772A1 (en) 2000-07-31 2001-07-16 Method of analyzing accumulated fat content in adipocytes

Country Status (2)

Country Link
AU (1) AU2001271054A1 (en)
WO (1) WO2002010772A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072767A1 (en) * 2004-01-30 2005-08-11 Intellectual Property Consulting Incorporated Agent for improving sugar metaboic function

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505373A (en) * 1992-11-20 1996-06-11 アムジエン・インコーポレーテツド B cell precursor stimulator
JP2000506370A (en) * 1995-11-15 2000-05-30 マサチューセッツ インスティチュート オブ テクノロジー How to regulate cholesterol transport
WO2000062073A1 (en) * 1999-04-12 2000-10-19 Sumitomo Chemical Company, Limited Method for analyzing the amount of intraabdominal adipose tissue

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505373A (en) * 1992-11-20 1996-06-11 アムジエン・インコーポレーテツド B cell precursor stimulator
JP2000506370A (en) * 1995-11-15 2000-05-30 マサチューセッツ インスティチュート オブ テクノロジー How to regulate cholesterol transport
WO2000062073A1 (en) * 1999-04-12 2000-10-19 Sumitomo Chemical Company, Limited Method for analyzing the amount of intraabdominal adipose tissue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAMAL B. ET AL., MOLECULAR AND CELLULAR BIOLOGY, vol. 14, no. 2, 1994, pages 1431 - 1437, XP002947539 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072767A1 (en) * 2004-01-30 2005-08-11 Intellectual Property Consulting Incorporated Agent for improving sugar metaboic function

Also Published As

Publication number Publication date
AU2001271054A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
EP0652436A3 (en) Bio-sensor for measuring alcohol concentration, method for manufacturing the bio-sensor and drunkometer using the same.
SG104946A1 (en) Bearing test method, bearing test device, bearing monitoring device and storage device
AU2002902A (en) Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker
AU2001288032A1 (en) Method and kit for the transderaml determination of analyte concentration in blood
HK1053510A1 (en) Test element analysis system, test element and method
AU6753800A (en) Method and apparatus for enhancing physical and cardiovascular health, and also for evaluating cardiovascular health
WO2002008461A3 (en) A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS
WO2001082793A3 (en) Method and device for testing a sample of fresh whole blood
EP1115389A4 (en) Fructosamine oxidase: antagonists and inhibitors
AU2001226354A1 (en) Fixative system, method and composition for biological testing
WO2000001845A3 (en) Method for early diagnosis of carcinomas
AU2002213279A1 (en) Method for analyzing text and method for builing text analyzers
MXPA02005796A (en) Electrochemical test strip for use in analyte determination.
GB0301159D0 (en) System and method for searching,finding and contacting dates on the internet in instant messaging networks and/or in other metods
HUP0203499A3 (en) Method and kit for determining the concentration of a neonicotinoid insecticide and antibodies applied in the test
HK1022007A1 (en) Method, member, and tendon for constructing an anchoring device.
AU2002224831A1 (en) Kit and method for determining multiple analytes
DE69725498D1 (en) Device and method for determining non-hemolized, occult blood levels in urine
ES2154703T3 (en) PROCEDURE FOR THE SPECIFIC DETECTION OF AN ACTIVATED COAGULATION FACTOR WITH A STABILITY ELEVATED AGAINST ACTIVATED PROTEIN C.
IL143098A0 (en) A method of detecting the presence of an analyte in a biological sample
EP1096256A4 (en) Chromatography quantitative measurement device, chromatography quantitative measurement method, and chromatography test piece used therefor
EP0831329A3 (en) Automatic analyser
EP1652918A3 (en) Methods for detecting protein interactions using conformationally constrained peptides
WO2000068424A3 (en) Means for detecting and treating pathologies linked to fgfr3
ATE285581T1 (en) ASSAY PROCEDURE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase